Chao-hsuan Chang

Title: The Innovative Contributions of Chao-hsuan Chang

Introduction

Chao-hsuan Chang, an accomplished inventor based in Taipei, Taiwan, has made significant strides in the field of biotechnology. With a focus on treating hyperglycemia, she holds one patent that showcases her innovative approach to addressing health challenges related to diabetes mellitus.

Latest Patents

Her most notable patent is centered on the "Use of a polysaccharide mixture for treating hyperglycemia." This invention describes a novel application of a polysaccharide mixture that includes about 30-50% (wt %) of β(1→3) glucan and β(1→6) glucan, with a molecular weight of at least 500,000. The mixture can be administered to individuals suffering from hyperglycemia in doses ranging from 1 to 1,000 mg/Kg, effectively ameliorating or alleviating symptoms associated with this condition.

Career Highlights

Chao-hsuan Chang's career has been characterized by her commitment to research and innovation. As an integral member of Trineo Biotechnology Co. Ltd., she is at the forefront of developments that contribute to better health outcomes for individuals experiencing hyperglycemia.

Collaborations

Throughout her career, Chao-hsuan Chang has worked alongside esteemed colleagues, including Cheng-Po Huang and Cheng-Chiu Tsao. These collaborations have enriched her research and have resulted in advancements that reflect the synergy of inventive minds working together.

Conclusion

Chao-hsuan Chang exemplifies the spirit of innovation within the biotechnology field. Her patented work provides a promising avenue for the treatment of hyperglycemia and demonstrates the impact of her contributions on healthcare. As she continues her journey, her inventions will undoubtedly play a crucial role in shaping future advancements in diabetes treatment.